Načítá se...
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Four fluid-based biomarkers have been developed into diagnostic tests for Alzheimer’s disease (AD) pathology: the ratio of 42 to 40 amino acid-long amyloid β, a marker of plaque pathology; total-tau and phosphorylated tau, markers of AD-related changes in tau metabolism and secretion; and neurofilam...
Uloženo v:
| Vydáno v: | Mol Neurodegener |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7893769/ https://ncbi.nlm.nih.gov/pubmed/33608044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-021-00430-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|